- Home
- KALV vs ZH Comparison
KALV vs ZH Comparison
Compare KALV & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- ZH
- Stock Information
- Founded
- KALV N/A
- ZH 2011
- Country
- KALV United States
- ZH China
- Employees
- KALV N/A
- ZH N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- ZH Business Services
- Sector
- KALV Health Care
- ZH Consumer Discretionary
- Exchange
- KALV Nasdaq
- ZH Nasdaq
- Market Cap
- KALV 362.2M
- ZH 304.3M
- IPO Year
- KALV N/A
- ZH 2021
- Fundamental
- Price
- KALV $8.75
- ZH $3.47
- Analyst Decision
- KALV Strong Buy
- ZH Strong Buy
- Analyst Count
- KALV 7
- ZH 2
- Target Price
- KALV $27.00
- ZH $5.65
- AVG Volume (30 Days)
- KALV 319.9K
- ZH 189.0K
- Earning Date
- KALV 03-10-2025
- ZH 11-26-2024
- Dividend Yield
- KALV N/A
- ZH N/A
- EPS Growth
- KALV N/A
- ZH N/A
- EPS
- KALV N/A
- ZH N/A
- Revenue
- KALV N/A
- ZH $552,853,374.00
- Revenue This Year
- KALV N/A
- ZH N/A
- Revenue Next Year
- KALV N/A
- ZH $8.26
- P/E Ratio
- KALV N/A
- ZH N/A
- Revenue Growth
- KALV N/A
- ZH N/A
- 52 Week Low
- KALV $7.30
- ZH $2.55
- 52 Week High
- KALV $16.88
- ZH $5.28
- Technical
- Relative Strength Index (RSI)
- KALV 51.87
- ZH 48.95
- Support Level
- KALV $7.30
- ZH $3.19
- Resistance Level
- KALV $9.16
- ZH $3.50
- Average True Range (ATR)
- KALV 0.41
- ZH 0.15
- MACD
- KALV 0.07
- ZH -0.01
- Stochastic Oscillator
- KALV 78.17
- ZH 43.08
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.